Related Experiment Videos
[Ototoxicity tests for T-2588 in rats]
The Japanese Journal of Antibiotics
|September 1, 1986
Summary
The T-2588 drug did not cause ototoxicity in rats, unlike kanamycin (KM), which showed hair cell loss in the inner ear. This study investigated potential hearing and balance damage from T-2588.
Area of Science:
- Ototoxicology
- Neuroscience
- Pharmacology
Context:
- Investigating the ototoxic potential of novel compounds is crucial for drug safety.
- Kanamycin (KM) is a known ototoxic antibiotic, serving as a positive control.
- Assessing inner ear damage requires evaluating both cochlear and vestibular functions.
Purpose:
- To evaluate the ototoxic effects of T-2588 on the spiral and vestibular organs.
- To compare the ototoxicity of T-2588 with that of kanamycin (KM) in Sprague-Dawley rats.
- To determine if T-2588 causes hearing or balance impairment.
Summary:
- T-2588 administration at 500 and 1,000 mg/kg/day orally for 5 weeks did not result in pinna reflex impairment or histopathological changes in the cochlea or vestibulum.
- Kanamycin (KM) at 200 mg/kg/day caused outer hair cell loss and vestibular hair cell loss, while 400 mg/kg/day KM induced more severe cochlear and vestibular damage.
- These findings indicate T-2588 has a favorable safety profile regarding ototoxicity compared to kanamycin.
Impact:
- Provides evidence for the non-ototoxic nature of T-2588, supporting its potential clinical development.
- Highlights the differential ototoxic effects of T-2588 versus kanamycin, aiding in risk assessment.
- Contributes to the understanding of inner ear drug toxicity mechanisms.